News | April 23, 2024
Devyser Diagnostics AB announces today it has entered into a co-marketing agreement with Hamilton Bonaduz AG, a leading global manufacturer of laboratory automation technology.
The partnership enables Devyser to collaboratively market Hamilton liquid handling technologies, and to facilitate the automation of library preparation of Devyser NGS kits. This enables labs to benefit from a combined solution of simple, fast, and accurate genetic testing solutions from Devyser alongside precise and reliable automation technologies from Hamilton, thereby enhancing the product value for both companies.
“Devyser strives to partner with global leaders in their respective fields, making Hamilton and its standardized automation technologies a perfect fit,” said Fredrik Alpsten, Devyser CEO. “The partnership allows genetic laboratories fast access to highly automated workflows that speed up processing time and improves data integrity for better patient safety.”
For more information, please contact:
Fredrik Alpsten, CEO
E-mail: fredrik.alpsten@devyser.com
Telephone: +46 70 667 31 06
Theis Kipling, CCO
E-mail: theis.kipling@devyser.com
Telephone: +46 73 598 07 76
About Devyser
Devyser develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. Our products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up. Devyser's products, and unique, patented solution requiring only one test tube, simplify genetic testing processes, improve sample throughput, minimize hands-on time and deliver rapid results. Our goal is for every patient to receive a correct diagnosis in the shortest possible time. Sustainability is a central part of our business and an important prerequisite for long term value creation.
Devyser was founded in 2004 and is based in Stockholm, Sweden with eight in-house sales offices in Europe and the US. The company also runs Devyser Genomic Laboratories, a CLIA certified laboratory in Atlanta, US. In 2022, Devyser's quality management system was certified according to the IVDR and a number of the company's products have since been certified according to the IVDR.
Devyser's shares are listed on the Nasdaq First North Premier Growth Market Stockholm (ticker: DVYSR). The company's Certified Adviser is Redeye AB.
About Hamilton
Hamilton is a leading global manufacturer, providing automated liquid handling workstations and laboratory automation technology to the scientific community. With a focus on innovative design, Hamilton products incorporate patented liquid handling technologies into a portfolio that includes liquid handling platforms, standard application-based solutions, small devices, consumables, and OEM liquid handling solutions.
Known for advancing life science, clinical diagnostics, forensics, and biotechnology industries, Hamilton products offer reliability, performance, and flexibility. Ensuring a continuous commitment to quality, Hamilton utilizes state-of-the-art manufacturing at production facilities in Reno, Nevada, and Bonaduz, Switzerland and has earned a global ISO 9001 certification. Privately held, Hamilton maintains headquarters in Reno, Nevada; Franklin, Massachusetts; and Bonaduz, Switzerland, along with subsidiary offices throughout the world.
www.hamiltoncompany.com/robotics
For more information on Hamilton, please contact:
Carsten Vischer, Business Development Manager Partnering
Email: partnering.rods.ch@hamilton.ch
